Timothy Spiro, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
University of Connecticut Fellowship
Fellowship
Case Western Reserve University - University Hospitals
Fellowship
University of Western Australia Faculty of Medicine
Medical School
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2018
Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience.
Randhawa JS, Budd GT, Randhawa M, Ahluwalia M, Jia X, Daw H, Spiro T, Haddad A; Am. J. Clin. Oncol.. 2016-12-01.
See more >>New anticoagulants in cancer patient treatments.
Arobelidze S, Haddad A, Spiro T, Daw H; Anticancer Drugs. 2016-10-01.
See more >>Gene expression profiling for early-stage NSCLC.
Petrosyan F, Daw H, Haddad A, Spiro T, Sood R; Am. J. Clin. Oncol.. 2015-02-01.
See more >>Practical recommendations on incorporating new oral anticoagulants into routine practice.
Randhawa J, Thiruchelvam N, Ghobrial M, Spiro T, Clark B, Haddad A, Daw H; Clin Adv Hematol Oncol. 2014-10-01.
See more >>5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.
Abou El Fadl, M.H., Bagai, R.K., Spiro, T.P., Daw, H.A.; Gastrointest Cancer Res. 2009-07-01
See more >>